Podcast Summary: The Tim Ferriss Show #823
Guest: Dr. Jeffrey Goldberg — Professor & Chair of Ophthalmology, Stanford University
Date: August 20, 2025
Theme: Creating Supranormal Vision, Cutting-Edge Science for Eye Health, Supplements, Red Light Therapy, and The Future of Eyesight Restoration
Episode Overview
In this episode, Tim Ferriss dives deep into the science and future of eye health with Dr. Jeffrey Goldberg, a leading ophthalmologist and researcher at Stanford. Driven by his personal experience of age-related vision decline (presbyopia), Tim explores how to not just prevent and repair loss of eyesight but even enhance visual performance to “supranormal” levels. The conversation covers a range of topics including supplements, vision training, red and violet light therapies, neuro-protection, the relationship between vision and cognitive health, stem cells, the immune system, and the coming wave of eyesight restoration technologies.
Key Discussion Points & Insights
1. The Nature of Vision Decline and Supranormal Performance
- Presbyopia and Emotional Impact:
Tim shares his struggles with near-vision loss, previously having 20/10 vision, and feeling a "crisis of meaning" as it changed his sense of identity.
"I've always had 2010 vision and this is unacceptable for me. ... My identity [was] based on ... very, very good eyesight and visual acuity for my entire life." (00:00–07:00) - Defining Supranormal Vision:
Dr. Goldberg explains that human vision can be trained beyond “normal,” as seen in elite athletes with 20/12 or even 20/10 vision.
"A lot of pro athletes have that... Can we train to supranormal vision? Can we induce? And almost no one studies that." (08:45) - Training Tools:
Discussion of goggles and devices that reduce effective visual frame rate to force brain adaptation—pro athletes train with "degraded" vision, then perform better when visual data is restored.
"Some of these supranormal visual tactics are actually trainable and there's tools that athletes are using, but they're accessible to all of us." (10:32)
2. Anatomy of the Eye — Vision 101
- Structural Breakdown:
Dr. Goldberg provides a concise eye anatomy lesson to explain where interventions can act:- Cornea (bends light)
- Pupil/Iris (controls light entry)
- Lens (fine focus; stiffens with age)
- Vitreous (gel middle; floaters)
- Retina (rods for night, cones for color/day; signals become neural)
- Optic nerve (to brain) "Our retinas are what we call inverted ... they absorb the light like the photons of light ... The rods are really only good for nighttime vision ... cones are great for color vision." (14:36)
- Why This Matters:
Understanding parts allows targeted interventions (supplements, training, light therapies).
3. Supplements: Hope vs. Hype
- AREDS2 and Others:
AREDS2 formula (lutein, zeaxanthin, etc.) is proven for moderate macular degeneration, but “probably not going to hurt” for others even if data is unclear.
"If you have moderate age-related macular degeneration [they help]... If you have mild ... or none ... can't prove it helps, but feel free." (21:28) - Other Notables:
- Vitamin B3 (nicotinamide): Being studied for glaucoma/neuro-protection (international clinical trials)
- CoQ10, ginkgo: Mixed data but low downside.
- Takeaway:
Supplements show most benefit for those with specific eye conditions, but some trends (Vitamin B3) are promising for broader applications.
4. Neuroscience: Vision Training, Plasticity, Psychedelics
- Visual Perceptual Training:
Computerized exercises (e.g., identifying blurred circles) may, through neuroplasticity, retrain the eye-brain connection for improved vision. Improvement is greater when paired with physical/motor responses.
"Your ability to train off of that is significantly better if it demands a behavioral outcome, a motor action." (27:36) - Post-Concussion Rehab:
Visual exercises help restore baseline function after traumatic brain injury—possible implications for taking vision “from normal to supranormal.” - Psychedelics & Microdosing:
Early research hints that low doses (LSD, etc.) can reopen critical periods of plasticity, possibly improving visual performance by acting on retina-brain pathways.
"There's clear evidence that these are relevant and likely to have some effects. ... About a third of our brain ... processes vision." (24:38) - Memorable Quote:
“These things act on the brain, and about a third of our brain inside our skull is dedicated to processing vision.” (24:38)
5. Red Light & Violet Light Therapy
- For Myopia and Eye Health:
Small daily doses of red light can slow myopia in children. Violet light shows similar effects. Both types of light likely work via the mitochondria, improving cellular energy delivery and possibly offering neuroprotection.
"A small dose of daily red light can slow down progression of myopia in young people… also works with violet light… mechanism is giving a little protective booster shot to our mitochondria." (33:21) - For Age-related Eye Disease:
Approved for macular degeneration treatment; “minutes, not hours” of daily exposure seems effective. - Caveat:
Data is early-stage for healthy adults and self-experimentation is “probably not going to hurt,” but optimal dose/brightness is unclear.
6. Vision, Cognitive Health & Mental Well-being
- Vision Loss Linked to Cognitive Decline:
Visual loss accelerates dementia and depression. Restoring sight (e.g., through cataract surgery) can reverse cognitive/mental decline.
"Visual decline accelerates cognitive decline ... but if you do cataract surgery and restore vision ... you can reverse a significant amount of that decline." (37:44) - Mythbusting on Glasses:
Wearing reading glasses does not make presbyopia worse—progressive lens stiffening happens regardless.
"You’re going to progress through those numbers whether you wear the readers or not. So wear the readers." (39:36)
7. Cutting-Edge & Experimental Interventions
- Stem Cells for Glaucoma/Restoration:
Retinal ganglion cell transplants are showing increasing promise in animal models, but human applications are not ready.
"Don't go to some clinic that's telling you they'll give you stem cells ... it is not ready for that yet." (51:59) - Cannabis and Eye Pressure:
THC/other cannabinoids transiently lower eye pressure (good for glaucoma), but require constant dosing—thus not practical. Active ingredients being studied for non-psychoactive options.
"It only really lowers the eye pressure during that time that you're getting high... you'd have to be high 24/7." (47:44) - Anti-inflammatories & the Immune System:
Immune modulation and anti-inflammatory therapies are emerging as central in vision protection, leveraging recent discoveries in innate immunity and neurodegeneration. - Microbiome & Vision:
Gut bacteria and immune system interaction are being recognized for their role in eye diseases—paralleling trends in systemic health.
8. Practical Eye Health Guidance
- Eye Exams:
Baseline exam by 40; more frequent for family history or risk factors; annual if diabetic. - Sunglasses and UV:
UV protection prevents cataract development. Full-spectrum (non-UV) light may help prevent childhood myopia. - Dry Eye:
Use artificial tears. If using many drops daily, switch to preservative-free versions.
"We usually recommend ... preservative-free artificial tears ... that [preservative] is actually irritating and kind of inflammatory." (63:55) - Serum & Growth Factors:
For severe dry eye, blood serum or platelet-rich plasma drops, rich in growth factors, are under study and sometimes used clinically.
9. The Future: Restoration, Augmentation & Research Participation
- Vision Restoration Is Coming:
The old dogma—vision lost is gone forever—is about to topple. Approaches combining molecular, cellular (stem cells), neuroplasticity, and digital/AR interventions are converging for actual restoration of eyesight.
"We are about to get into vision restoration at a level that has been totally unexpected ... that is going to be the biggest topple." (74:17) - Interfacing with Brain Science:
Similar principles will drive brain and cognition restoration; vision science leads the way due to anatomical accessibility. - Clinical Trials:
Participation is highly encouraged—patients benefit while enabling progress.
Find trials at: ClinicalTrials.gov or disease foundation websites. - Stanford Resource:
The Stanford Ophthalmology Clinical Trials page lists active studies: search for "Stanford Ophthalmology Clinical Trials" online.
Notable Quotes & Memorable Moments
On Supranormal Vision Training
"Can we train to supranormal vision? ... There are some really cool tools ... if we practiced and trained in those goggles where you've gotta play basketball ... at 70% vision, and then we put you in the game back with 100% vision. You're going to be better, faster reflex time, all of that."
— Dr. Jeffrey Goldberg (08:45–11:32)
On Supplements
"Clinically proven ... AREDS2, if you have moderate age-related macular degeneration to slow down your vision loss ... we can't prove it's helping [in others], but feel free."
— Dr. Goldberg (21:28)
On Vision Loss & Cognition
"Visual decline accelerates cognitive decline...but if you do cataract surgery and restore vision...you can reverse a significant amount of that decline."
— Dr. Goldberg (37:44)
On Reversibility of Vision Loss
"We have always said...once you've lost whatever vision you've lost, I can't get that back for you. And I think that is about to topple."
— Dr. Goldberg (74:17)
On Participating in Science
"I know you're grateful to be in this trial, but I'm grateful to you too—we are grateful to the patient. We've all got to participate in science as a community."
— Dr. Goldberg (93:35)
Timestamps of Key Segments
- 00:00 — Tim’s introduction; personal motivation for vision deep-dive
- 07:30–14:00 — What is supranormal vision? Athlete examples, training tools introduction
- 14:04–17:27 — Vision 101: Eye anatomy explained and why it matters
- 21:26–25:12 — Supplements: AREDS2, vitamin B3, and emerging trends
- 27:26–30:21 — Computerized vision training, concussion rehab, behavioral learning
- 33:11–36:05 — Red/violet light therapies: use for myopia, mitochondrial health, and caveats
- 37:44–41:13 — Vision and cognitive health; the myth around glasses “making vision worse”
- 46:46–54:02 — Glaucoma: risk, measurement, role of cannabis, stem cell prospects
- 54:02–61:31 — Inflammation, immune system, the microbiome’s role in eye disease
- 63:25–68:43 — Dry eye, preservative-free tears, serum, and platelet-rich plasma treatments
- 69:00–73:25 — Practical advice: exam frequency, sunglasses, full-spectrum light, childhood myopia
- 74:10–81:58 — Future paradigm shifts: vision restoration is near, eye-brain science converging
- 82:47–89:26 — Mitochondrial function, maternal inheritance, interventions beyond red light
- 90:07–91:20 — Exercise as neuro- and eye-health intervention (“none to some” principle)
- 95:21–99:40 — The pivotal role of clinical trials; how and where to participate
Additional Resources & Where to Learn More
- Clinical Trials: ClinicalTrials.gov
- Stanford Ophthalmology Clinical Trials: Search “Stanford Ophthalmology Clinical Trials” for current studies
- Disease-Specific Foundations: Glaucoma Research Foundation, Macular Degeneration Foundation
Final Thoughts
This episode delivers a comprehensive, optimistic, and actionable guide to modern eye health—from practical tips to cutting-edge research. Dr. Goldberg emphasizes a new era where vision loss is not just preventable but (in the foreseeable future) reversible. The eye stands as both a window into and a direct outpost of the brain, making it a fertile ground for interventions in both vision and cognition.
"The biggest difference in your life was going from none to some."
— Dr. Jeffrey Goldberg (90:42)